Cargando…
Long Non-Coding RNA PVT1 Regulates the Resistance of the Breast Cancer Cell Line MDA-MB-231 to Doxorubicin via Nrf2
Triple-negative breast cancer (TNBC) is one of the most common malignant tumor types in females and its drug resistance is a major clinical issue. An increasing number of long non-coding RNAs (lncRNAs) have been reported as key regulators of drug resistance in TNBC. Plasmacytoma variant translocatio...
Autores principales: | Luo, Ying, Zhang, Wei, Xu, Liang, Chen, Yajun, Xu, Yao, Yuan, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750900/ https://www.ncbi.nlm.nih.gov/pubmed/33327894 http://dx.doi.org/10.1177/1533033820980763 |
Ejemplares similares
-
Parthenolide prevents resistance of MDA-MB231 cells to doxorubicin and mitoxantrone: the role of Nrf2
por: Carlisi, Daniela, et al.
Publicado: (2017) -
Arctigenin Enhances the Cytotoxic Effect of Doxorubicin in MDA-MB-231 Breast Cancer Cells
por: Lee, Kyu-Shik, et al.
Publicado: (2020) -
Effects of FSTL1 on cell proliferation in breast cancer cell line MDA-MB-231 and its brain metastatic variant MDA-MB-231-BR
por: An, Jiaqiang, et al.
Publicado: (2017) -
Long non-coding RNA HOTAIR enhances radioresistance in MDA-MB231 breast cancer cells
por: Zhou, Yun, et al.
Publicado: (2017) -
Differential Expression of HSP90β in MDA-MB-231 and MCF-7 Cell Lines after Treatment with Doxorubicin
por: Jokar, Fereshte, et al.
Publicado: (2019)